Company
NYSE:JNJ
Johnson & Johnson is a diversified healthcare products company. The company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through two segments: Pharmaceutical and MedTech.
152 stories · page 4 of 8
The settlement, which Shine Lawyers said was the largest settlement in a product liability class action in Australian history, follows multiple court proceedings involving more than 11,000 claimants, the pharmaceutical giant, and its subsid
Due to a barrage of legal challenges and 'misinformation' about product's safety, J&J announced in 2020 it would no longer sell its baby powder in North America and the US
At the London close, the UK blue-chip index was 27.94 points or 0.37% higher at 7,629.22, much nearer the session peak of 7,637.87 than the day’s early low of 7,590.62
Major customers for the vaccine including the African Union and Covax, the organisation focused on supplying vaccines equally around the world,
J&J is facing litigation from tens of thousands of people alleging that its talc products contain asbestos and can cause cancer
Archive
"Having reversed all its Monday losses in yesterday’s session, US markets have continued to move higher in early trade," said Michael Hewson, chief market analyst at CMC Markets
The European Medicines Agency stated that these events should be listed as very rare side effects of the jab
The authorities said this decision was taken “out of an abundance of caution” while investigations are ongoing
Archive
JNJ stock lost more than 1% to close at $159.56 Tuesday after the CDC and FDA recommended a pause in the use of its coronavirus vaccine
Data for the week to March 6 showed 712,000 Americans filed for unemployment, down from 754,000 the previous week and below estimates of 725,000
The authorisation is expected to boost the country's immunisation programme
Johnson & Johnson said its vaccine was also effective at preventing asymptomatic infections
Johnson & Johnson’s target is to administer one billion doses of the vaccine worldwide in 2021
The jab fell short of its competitors in terms of protection but it only needs one shot to work
There is much anticipation for data on the company's candidate even though some competitors have been rolled out in several countries of the world
Archive
Traders tried to plot a course as US lawmakers in the House of Representatives kicked off a debate on fresh impeachment charges against Trump
The pharma giant is looking to see whether two doses can protect patients for longer
Investors seem to have adjusted to the ups and downs of vaccine development, though they are hoping trials can resume soon
It is not clear whether the individual received a study treatment or a placebo
Archive
The S&P 500, Dow and Nasdaq are down 7.5%, 5.9% and 9.7%, respectively, for the month
